165 related articles for article (PubMed ID: 8390809)
21. First occurrence of transferable extended-spectrum beta-lactamase hydrolyzing cefoperazone in multiresistant nosocomial strains of Klebsiella pneumoniae from two hospitals in Czech and Slovak Republics.
Blahová J; Králiková K; Krćméry V; Vaculíková A; Jezek P
J Chemother; 2002 Oct; 14(5):461-4. PubMed ID: 12462425
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of beta-lactam drugs and sulbactam against Chlamydia trachomatis.
Segreti J; Kapell KS; Trenholme GM
Diagn Microbiol Infect Dis; 1992; 15(4):371-3. PubMed ID: 1611854
[TBL] [Abstract][Full Text] [Related]
23. High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.
Rice LB; Carias LL; Hujer AM; Bonafede M; Hutton R; Hoyen C; Bonomo RA
Antimicrob Agents Chemother; 2000 Feb; 44(2):362-7. PubMed ID: 10639363
[TBL] [Abstract][Full Text] [Related]
24. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.
Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T
mBio; 2020 Apr; 11(2):. PubMed ID: 32291303
[TBL] [Abstract][Full Text] [Related]
25. In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters.
Fass RJ; Gregory WW; D'Amato RF; Matsen JM; Wright DN; Young LS
Antimicrob Agents Chemother; 1990 Nov; 34(11):2256-9. PubMed ID: 2073118
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of sulperazon against recent isolates of ceftazidime-resistant bacteria.
Lim VK; Halijah MY
Med J Malaysia; 2001 Sep; 56(3):365-9. PubMed ID: 11732084
[TBL] [Abstract][Full Text] [Related]
27. In-vitro activity of cefoperazone-sulbactam combination against cefoperazone resistant clinical isolates in a Malaysian general hospital.
Lim VK; Cheong YM
Malays J Pathol; 1995 Dec; 17(2):73-6. PubMed ID: 8935129
[TBL] [Abstract][Full Text] [Related]
28. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
Wang FD; Lin ML; Lee WS; Liu CY
Int J Antimicrob Agents; 2004 Jun; 23(6):590-5. PubMed ID: 15194130
[TBL] [Abstract][Full Text] [Related]
29. In-vitro activity of cefoperazone-sulbactam against Bacteroides species.
Souza Dias MB; Jacobus NV; Tally FP
J Antimicrob Chemother; 1986 Oct; 18(4):467-71. PubMed ID: 3021709
[TBL] [Abstract][Full Text] [Related]
30. Comparative in vitro activity of cefoperazone and various combinations of cefoperazone/sulbactam.
Knapp CC; Sierra-Madero J; Washington JA
Diagn Microbiol Infect Dis; 1990; 13(1):45-9. PubMed ID: 2331849
[TBL] [Abstract][Full Text] [Related]
31. In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and beta-lactamase studies.
Jones RN; Wilson HW; Thornsberry C; Barry AL
Diagn Microbiol Infect Dis; 1985 Nov; 3(6):489-99. PubMed ID: 2998694
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of cefoperazone/sulbactam and other antimicrobials against anaerobic bacteria.
D'Amato RF; Hochstein L; Frankel H
Diagn Microbiol Infect Dis; 1990; 13(1):51-5. PubMed ID: 2331850
[TBL] [Abstract][Full Text] [Related]
33. Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam.
Bradford PA; Sanders CC
Antimicrob Agents Chemother; 1992 Feb; 36(2):394-400. PubMed ID: 1605604
[TBL] [Abstract][Full Text] [Related]
34. Augmentation in zone of inhibition of cefoperazone/cefoperazone+ sulbactum compares well with the clinical laboratory standard institute standard extended spectrum beta-lactamase detection method as well as the polymerase chain reaction method.
Chitnis S; Katara G; Hemvani N; Chitnis DS
Curr Drug Saf; 2011 Jul; 6(3):155-8. PubMed ID: 22122390
[TBL] [Abstract][Full Text] [Related]
35. In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci.
Barry AL; Jones RN
Antimicrob Agents Chemother; 1990 Sep; 34(9):1830-2. PubMed ID: 2285302
[TBL] [Abstract][Full Text] [Related]
36. Activity of sulbactam combinations against Escherichia coli isolates with known amounts of TEM-1 beta-lactamase.
Livermore DM
J Antimicrob Chemother; 1992 Feb; 29(2):222-4. PubMed ID: 1506339
[No Abstract] [Full Text] [Related]
37. In vitro activity of cefoperazone-sulbactam combination against gram negative bacilli.
Poudyal N; Gyawali N; Gurung R; Bhattarai NR; Baral R; Khanal B; Shrestha S; Amatya R; Bhattacharya SK
Nepal Med Coll J; 2012 Mar; 14(1):5-8. PubMed ID: 23441486
[TBL] [Abstract][Full Text] [Related]
38. Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
Mohanty S; Singhal R; Sood S; Dhawan B; Das BK; Kapil A
Indian J Med Res; 2005 Nov; 122(5):425-8. PubMed ID: 16456257
[TBL] [Abstract][Full Text] [Related]
39. In vitro comparison of cefoperazone/sulbactam with selected antimicrobials against 300 bacteroides isolates. Inhibitory activity and time-kill kinetic studies.
Gelfand MS; Grogan JT; Haas MJ
Diagn Microbiol Infect Dis; 1989; 12(5):421-8. PubMed ID: 2612130
[TBL] [Abstract][Full Text] [Related]
40. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Turk Dagi H; Kus H; Arslan U; Tuncer I
Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
